Comparative Assessment of Diagnostic Homologous Recombination Deficiency associated mutational signatures in ovarian cancer
Clinical Cancer Research, 2021
M.D., Ph.D. · Research Fellow, Harvard Medical School
Cancer Genomics · DNA Repair · Precision Medicine
I am a physician-scientist with a background in oncology, cancer genomics, computational medicine, and artificial intelligence. I am currently a Research Fellow at Harvard Medical School and Boston Children's Hospital in the Computational Health Informatics Program, and an affiliate researcher at the Danish Cancer Institute.
My research focuses on using computational biology, machine learning, and AI to study cancer genomics and develop clinically relevant biomarkers. Over the years, I have worked on several areas of cancer research, including DNA repair deficiencies such as homologous recombination deficiency (HRD) and nucleotide excision repair (NER) defects, immuno-oncology, liquid biopsies, computational pathology, and the use of large language models in medicine and scientific discovery.
I developed scarHRD, an R package for estimating HRD from tumor sequencing data. It has been used and cited in more than 300 scientific publications. I also created TCGA Explorer, a no-code platform that allows researchers to analyse data across 30 TCGA cancer types without programming. My aim with these tools is to make cancer data analysis more accessible, reproducible, and useful for researchers and clinicians.
I have published 52 peer-reviewed papers, with more than 2,200 citations and an h-index of 25 on Google Scholar. I am also an inventor on patent WO2021195390A2.
I also write and make videos about integrating AI and large language models into real research workflows — from everyday LLM use and AI co-scientists to agentic coding — with a focus on doing so productively and responsibly. See Writing & Talks.
My research aims to identify DNA repair deficiencies and develop companion diagnostics through computational approaches. I integrate medical expertise with machine learning and statistical modeling to advance cancer treatment.
No-Code Cancer Genomics Platform
A browser-based platform for cancer genomics research — type a gene, run pan-cancer analyses across all 30 TCGA cancer types, and download comprehensive HTML reports. No coding required. Designed for researchers, bioinformaticians, and clinicians.
Pan-cancer expression across 30 TCGA cohorts + GTEx normal tissue comparisons
Cox regression and Kaplan-Meier curves across 4 survival endpoints
Immune infiltration scores, mutational signatures (COSMIC v2/v3/Indel)
DESeq2 analysis with GSEA enrichment and pathway annotation
ssGSEA explorer using MSigDB pathways; async background jobs (10–90 min) with downloadable HTML reports
Coverage: All 30 TCGA cancer types · GTEx normal tissue · COSMIC v2/v3/Indel · MSigDB pathways
Open-source R package for estimating homologous recombination deficiency from tumor sequencing data
Practical, honest notes and videos on using AI and large language models in real biomedical research — no hype, no AI slop.
Clinical Cancer Research, 2021
Nature Cancer, 2023
Clinical Cancer Research, 2020
Science, 2020
Total publications: 52 · Citations: 2,200 · h-index: 25
Patent: WO2021195390A2 — Method for treating cancer